Transaction · 0001628280-25-011310

BOYER ANDREW S

BOYER ANDREW S, EVP, reported an open-market or private sale at Amneal Pharmaceuticals, Inc. involving 125000.000000 shares for an estimated $1111250.00. Reported holdings after the transaction were 290106.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SEVP
AMRXAmneal Pharmaceuticals, Inc.
Filing timeMar 07
Trade dateMar 05, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

AMRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AMRX since 2025-03-07Filed 545 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-25-011310
Class A Common Stock
Transaction date
Mar 05, 2025
Filed Mar 07, 2025, 09:18 PM · 2d delay
Shares
125k sh
$889 per share
Estimated value
-$111M
Computed from shares × price
Holdings after
290k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction Large Sale
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Executive Vice President

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.70 to $9.00 per share, inclusive. The Reporting Person undertakes…

Original filing · 0001628280-25-011310
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AMRX